Marc P Girard

Summary

Country: France

Publications

  1. ncbi A review of vaccine research and development: meningococcal disease
    Marc P Girard
    University Paris 7, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 24:4692-700. 2006
  2. ncbi A review of vaccine research and development: tuberculosis
    Marc P Girard
    University Paris 7, UFR Biochemistry, 39 rue Seignemartin, 69008 Lyon, France
    Vaccine 23:5725-31. 2005
  3. ncbi Report of the 6th meeting on the evaluation of pandemic influenza vaccines in clinical trials World Health Organization, Geneva, Switzerland, 17-18 February 2010
    Marc P Girard
    French National Academy of Medicine, 39 rue Seignemartin, 69008 Lyon, France
    Vaccine 28:6811-20. 2010
  4. ncbi HIV/AIDS vaccines: a need for new concepts?
    Marc P Girard
    Paris 7 Denis Diderot University, Lyon, France
    Int Rev Immunol 27:447-71. 2008
  5. ncbi Mucosal immunity and HIV/AIDS vaccines. Report of an International Workshop, 28-30 October 2007
    Marc P Girard
    Universite Paris 7 Denis Diderot, Paris, France
    Vaccine 26:3969-77. 2008
  6. ncbi A review of human vaccine research and development: malaria
    Marc P Girard
    University Paris 7, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 25:1567-80. 2007
  7. ncbi A review of vaccine research and development: the human immunodeficiency virus (HIV)
    Marc P Girard
    University Paris 7, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 24:4062-81. 2006
  8. ncbi A review of vaccine research and development: human enteric infections
    Marc P Girard
    University Paris 7, UFR Biochemistry, 39 rue Seignemartin, 69008 Lyon, France
    Vaccine 24:2732-50. 2006
  9. ncbi A review of vaccine research and development: human acute respiratory infections
    Marc P Girard
    University Paris 7, UFR Biochemistry, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 23:5708-24. 2005
  10. ncbi Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011
    Marc P Girard
    French National Academy of Medicine, 39 rue Seignemartin, 69008 Lyon, France
    Vaccine 29:7579-86. 2011

Detail Information

Publications12

  1. ncbi A review of vaccine research and development: meningococcal disease
    Marc P Girard
    University Paris 7, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 24:4692-700. 2006
    ..However, effective global prevention of meningococcal disease will not be achievable without the development of a vaccine against Group B meningitis, for which outer membrane protein vaccines are under development...
  2. ncbi A review of vaccine research and development: tuberculosis
    Marc P Girard
    University Paris 7, UFR Biochemistry, 39 rue Seignemartin, 69008 Lyon, France
    Vaccine 23:5725-31. 2005
    ..This review summarizes recent advances in tuberculosis vaccine development...
  3. ncbi Report of the 6th meeting on the evaluation of pandemic influenza vaccines in clinical trials World Health Organization, Geneva, Switzerland, 17-18 February 2010
    Marc P Girard
    French National Academy of Medicine, 39 rue Seignemartin, 69008 Lyon, France
    Vaccine 28:6811-20. 2010
    ..However, a second dose of vaccine was needed to boost immune responses in infants and toddlers 6 months to 3 years of age and, with some vaccines, in children aged 3-9 years...
  4. ncbi HIV/AIDS vaccines: a need for new concepts?
    Marc P Girard
    Paris 7 Denis Diderot University, Lyon, France
    Int Rev Immunol 27:447-71. 2008
    ..As a result, the research community is faced with the daunting task of identifying novel vaccine concepts and products to continue the search. This review highlights and addresses some of the scientific and practical concerns...
  5. ncbi Mucosal immunity and HIV/AIDS vaccines. Report of an International Workshop, 28-30 October 2007
    Marc P Girard
    Universite Paris 7 Denis Diderot, Paris, France
    Vaccine 26:3969-77. 2008
    ..This report summarizes the main concepts and conclusions that came out of the meeting...
  6. ncbi A review of human vaccine research and development: malaria
    Marc P Girard
    University Paris 7, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 25:1567-80. 2007
    ..This article attempts to summarize the state of the art of malaria vaccine development...
  7. ncbi A review of vaccine research and development: the human immunodeficiency virus (HIV)
    Marc P Girard
    University Paris 7, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 24:4062-81. 2006
    ..This article reviews the state of the art in HIV vaccine development, summarizes the results obtained so far and discusses the challenges to be met in the development of the various vaccine candidates...
  8. ncbi A review of vaccine research and development: human enteric infections
    Marc P Girard
    University Paris 7, UFR Biochemistry, 39 rue Seignemartin, 69008 Lyon, France
    Vaccine 24:2732-50. 2006
    ..This article reviews the state of the art in vaccine R&D against human viral and bacterial enteric infections of public health importance...
  9. ncbi A review of vaccine research and development: human acute respiratory infections
    Marc P Girard
    University Paris 7, UFR Biochemistry, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 23:5708-24. 2005
    ..This article reviews the state of the art in vaccine R&D against ARIs and attempts to address these basic public health questions...
  10. ncbi Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011
    Marc P Girard
    French National Academy of Medicine, 39 rue Seignemartin, 69008 Lyon, France
    Vaccine 29:7579-86. 2011
    ..On the regulatory side, work should be undertaken to harmonize the results of serological tests used to evaluate the immunogenicity of traditional influenza vaccines...
  11. ncbi Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review
    Marc P Girard
    University Paris 7, French National Academy of Medicine, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 29:6191-218. 2011
    ..This article reviews the state of the art of HIV vaccine development and discusses the formidable scientific challenges met in this endeavor, in the context of a better understanding of the immunopathogenesis of the disease...
  12. ncbi The 2009 A (H1N1) influenza virus pandemic: A review
    Marc P Girard
    University Paris 7 Denis Diderot, 39 rue Seignemartin, 69008, Lyon, France
    Vaccine 28:4895-902. 2010
    ..The need for an increased surveillance of influenza virus circulation in swine is outlined...